287 related articles for article (PubMed ID: 27527149)
21. Elevated serum level of IL-33 and sST2 in patients with ankylosing spondylitis: associated with disease activity and vascular endothelial growth factor.
Li XL; Lin TT; Qi CY; Yuan L; Xia LP; Shen H; Lu J
J Investig Med; 2013 Jun; 61(5):848-51. PubMed ID: 23552178
[TBL] [Abstract][Full Text] [Related]
22. Serum bone-turnover biomarkers are associated with the occurrence of peripheral and axial arthritis in psoriatic disease: a prospective cross-sectional comparative study.
Jadon DR; Sengupta R; Nightingale A; Lu H; Dunphy J; Green A; Elder JT; Nair RP; Korendowych E; Lindsay MA; McHugh NJ
Arthritis Res Ther; 2017 Sep; 19(1):210. PubMed ID: 28934972
[TBL] [Abstract][Full Text] [Related]
23. Soluble intercellular adhesion molecule 1 in spondylarthropathies.
Wendling D; Racadot E; Augé B; Toussirot E
Clin Rheumatol; 1998; 17(3):202-4. PubMed ID: 9694052
[TBL] [Abstract][Full Text] [Related]
24. Broad proteomic screen reveals shared serum proteomic signature in patients with psoriatic arthritis and psoriasis without arthritis.
Leijten E; Tao W; Pouw J; van Kempen T; Olde Nordkamp M; Balak D; Tekstra J; Muñoz-Elías E; DePrimo S; Drylewicz J; Pandit A; Boes M; Radstake T
Rheumatology (Oxford); 2021 Feb; 60(2):751-761. PubMed ID: 32793974
[TBL] [Abstract][Full Text] [Related]
25. [Seronegative spondyloarthropathies].
Bernhard J
Ther Umsch; 2002 Oct; 59(10):529-34. PubMed ID: 12428438
[TBL] [Abstract][Full Text] [Related]
26. Increased perivascular synovial membrane expression of myeloid-related proteins in psoriatic arthritis.
Kane D; Roth J; Frosch M; Vogl T; Bresnihan B; FitzGerald O
Arthritis Rheum; 2003 Jun; 48(6):1676-85. PubMed ID: 12794836
[TBL] [Abstract][Full Text] [Related]
27. [Acquired hyperostosis syndrome alias arthroosteitis pustulosa (also an extension and comment on T. Nagel et. al.: Arthroosteitis pustulosa, pustulo-psoriatic hyperostotic spondylarthritis, SAPHO syndrome: clinical experiences and review of the literature].
Dihlmann W
Z Rheumatol; 1994; 53(3):164-8; author reply 169-70. PubMed ID: 8091871
[No Abstract] [Full Text] [Related]
28. Immune-Mediated Inflammation Promotes Subclinical Atherosclerosis in Recent-Onset Psoriatic Arthritis Patients without Conventional Cardiovascular Risk Factors.
Kolliker Frers RA; Cosentino V; Tau J; Kerzberg EM; Urdapilleta A; Chiocconi M; Kogan N; Otero-Losada M; Capani F
Front Immunol; 2018; 9():139. PubMed ID: 29535705
[TBL] [Abstract][Full Text] [Related]
29. Acne fulminans with synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome treated with infliximab.
Iqbal M; Kolodney MS
J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S118-20. PubMed ID: 15858507
[TBL] [Abstract][Full Text] [Related]
30. [Clinical Observation of Chaihu Guizhi Decoction in Treating SAPHO Syndrome].
Li C; Liu JH; Hao WX; Zhang W; Dong ZH
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2017 Apr; 37(4):429-432. PubMed ID: 30650500
[TBL] [Abstract][Full Text] [Related]
31. Successful Treatment of SAPHO Syndrome Complicated with Ankylosing Spondylitis by Secukinumab: A Case Report.
Tu W; Nie D; Chen Y; Wen C; Zeng Z
J Pers Med; 2023 Mar; 13(3):. PubMed ID: 36983699
[TBL] [Abstract][Full Text] [Related]
32. Association of intercellular adhesion molecule-1 with clinical manifestations and interleukin-18 in patients with active, untreated adult-onset Still's disease.
Chen DY; Lan JL; Lin FJ; Hsieh TY
Arthritis Rheum; 2005 Jun; 53(3):320-7. PubMed ID: 15934126
[TBL] [Abstract][Full Text] [Related]
33. One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter study.
Chimenti MS; Fonti GL; Conigliaro P; Sunzini F; Scrivo R; Navarini L; Triggianese P; Peluso G; Scolieri P; Caccavale R; Picchianti Diamanti A; De Martino E; Salemi S; Birra D; Altobelli A; Paroli M; Bruzzese V; Laganà B; Gremese E; Conti F; Afeltra A; Perricone R
Expert Opin Biol Ther; 2020 Jul; 20(7):813-821. PubMed ID: 32401062
[TBL] [Abstract][Full Text] [Related]
34. Is the health-related quality of life and functional status of patients with psoriatic arthritis worse than that of patients with psoriasis alone?
Tezel N; Yilmaz Tasdelen O; Bodur H; Gul U; Kulcu Cakmak S; Oguz ID; Karabulut E
Int J Rheum Dis; 2015 Jan; 18(1):63-9. PubMed ID: 24460852
[TBL] [Abstract][Full Text] [Related]
35. Serum soluble intercellular adhesion molecule 1 and interleukin 8 levels in familial Mediterranean fever.
Direskeneli H; Ozdogan H; Korkmaz C; Akoglu T; Yazici H
J Rheumatol; 1999 Sep; 26(9):1983-6. PubMed ID: 10493680
[TBL] [Abstract][Full Text] [Related]
36. TH17 cells are increased in the peripheral blood of patients with SAPHO syndrome.
Firinu D; Barca MP; Lorrai MM; Perra S; Cabras S; Muggianu E; Di Martino ML; Manconi PE; Del Giacco SR
Autoimmunity; 2014 Sep; 47(6):389-94. PubMed ID: 24720503
[TBL] [Abstract][Full Text] [Related]
37. Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis.
Daoussis D; Liossis SN; Solomou EE; Tsanaktsi A; Bounia K; Karampetsou M; Yiannopoulos G; Andonopoulos AP
Arthritis Rheum; 2010 Jan; 62(1):150-8. PubMed ID: 20039407
[TBL] [Abstract][Full Text] [Related]
38. [Comment on H. Kaiser: "Current aspects of SAPHO syndrome"].
Schilling F; Kaiser H
Z Rheumatol; 1996; 55(1):71-2; author reply 75. PubMed ID: 8868154
[No Abstract] [Full Text] [Related]
39. Increased levels of asymmetric dimethylarginine (ADMA) in patients with ankylosing spondylitis.
Sari I; Kebapcilar L; Alacacioglu A; Bilgir O; Yildiz Y; Taylan A; Yuksel A; Kozaci DL
Intern Med; 2009; 48(16):1363-8. PubMed ID: 19687580
[TBL] [Abstract][Full Text] [Related]
40. Suppressors of cytokine signalling in ankylosing spondylitis and their associations with disease severity, acute-phase reactants and serum cytokines.
Chen CH; Chen HA; Liao HT; Liu CH; Tsai CY; Chou CT
Clin Exp Rheumatol; 2016; 34(1):100-5. PubMed ID: 26812031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
